Today (March 3), A-Shares opened high and went low, led by the gem index, and the Shanghai index was relatively resistant to decline. On the disk, in terms of industries, shipping ports, gas, oil, logistics, coal, airports, trade, tourism and hotels, steel, cement and building materials, real estate and other industries led the increase; Battery, semiconductor, wine making, motor, computer equipment, communication equipment, consumer electronics, auto parts and other industries led the decline. In terms of subject stocks, China Russia trade concept, combustible ice, oil and gas equipment and services, shale gas, covid-19 drugs, online tourism and natural gas led the rise, while lidar, MLCC, RCS concept, blade battery, Huawei automobile, IGBT concept and hit battery led the decline.
covid-19 treatment concept stocks rose in the afternoon, and the industry market is expected to reach 100 billion
On Thursday afternoon, covid-19 treatment concept stocks continued to strengthen, with Chengda pharmaceutical rising by 20%, while Maiwei biology, Xinxiang Tuoxin Pharmaceutical Co.Ltd(301089) , Shanghai Junshi Biosciences Co.Ltd(688180) rising, Staidson(Beijing) Biopharmaceuticals Co.Ltd(300204) , Fujian Cosunter Pharmaceutical Co.Ltd(300436) , etc. followed. According to the news, the State Food and Drug Administration recently conducted emergency review and approval in accordance with the relevant provisions of the drug administration law and the special drug approval procedures, and conditionally approved the import registration of the combined packaging of nevitavir tablets / ritonavir tablets (i.e. paxlovid) of Pfizer covid-19 virus treatment drug.
Debang Securities believes that the State Food and Drug Administration approved the emergency use of Pfizer covid-19 specific drug paxlovid in China, the opening of the country is expected to be ahead of schedule, and the covid-19 therapeutic drug market is expected to reach 100 billion. It is the most important investment sector after covid-19 vaccine and covid-19 testing, and its sustainability is far beyond that of vaccine and testing, “Integration of Chinese and Western medicine” will be the mainstream of covid-19 treatment in China, focusing on covid-19 small molecules, industrial chain and anti-covid-19 traditional Chinese medicine.
Caitong Securities Co.Ltd(601108) pointed out that covid-19 oral medicine is the last puzzle of the epidemic and the most important event for the change of epidemic prevention policy. The FDA conditionally approved the registration and listing of Pfizer’s palovide import, as well as the successive large orders of boten and Asymchem Laboratories (Tianjin) Co.Ltd(002821) , becoming an important catalyst in the industry. According to the pricing of Pfizer palovide and mRNA vaccine, we should expect the listing of domestic covid-19 oral drug and new vaccine.
AVIC Securities said that according to the announcement and annual report previously released by Pfizer, the price of a single course of paxlovid is $529. It is expected that the revenue of covid-19 oral medicine will reach $22 billion in covid-19 treatment products in 2022. Covid-19 oral medicine, as the last puzzle in the current covid-19 treatment industry chain, has broad market prospects. In the short term, it is suggested to continue to pay attention to the investment opportunities in the R & D of covid-19 small molecule drugs, and pay attention to the listed companies deeply involved in the supply chain of covid-19 preventive drugs, including Shanghai Junshi Biosciences Co.Ltd(688180) -u, Porton Pharma Solutions Ltd(300363) and Asymchem Laboratories (Tianjin) Co.Ltd(002821) etc.
hydrogen energy concept pushed up Fujian Snowman Co.Ltd(002639) , Beijing Jingcheng Machinery Electric Company Limited(600860) and other daily limits Zhangjiagang Furui Special Equipment Co.Ltd(300228) and other higher
On the 3rd, the concept of hydrogen energy rose in intraday trading. As of press time, Lanpec Technologies Limited(601798) , Fujian Snowman Co.Ltd(002639) , Beijing Jingcheng Machinery Electric Company Limited(600860) , Elion Clean Energy Company Limited(600277) and other limits, Lanzhou Ls Heavy Equipment Co.Ltd(603169) , Kingfa Sci.& Tech.Co.Ltd(600143) , Zhangjiagang Furui Special Equipment Co.Ltd(300228) ., Houpu Clean Energy Co.Ltd(300471) , etc.
According to the data, China’s hydrogen demand will be about 33.42 million tons in 2020. By 2030, China’s annual hydrogen demand will increase to 37.15 million tons, accounting for about 5% of the terminal energy consumption. By 2060, China’s annual hydrogen demand will increase to about 130 million tons, accounting for about 20% of the terminal energy consumption. China’s hydrogen demand will gradually increase in the future. At present, China’s annual output of hydrogen ranks first in the world, with an annual output of 25 million tons. At the same time, China is also the world’s largest producer and marketer of hydrogen storage materials.
It is reported that China Petroleum & Chemical Corporation(600028) and national energy group are the two enterprises with the largest hydrogen production in China, accounting for 30% of the market share. There are many other hydrogen production enterprises, the scale of hydrogen production is relatively small, and the market competition pattern is relatively scattered. The agency said that as other large central enterprises enter the hydrogen energy industry, the market concentration of the hydrogen energy industry is expected to increase in the future. At present, more than one-third of central enterprises are in the layout of the whole industrial chain, including hydrogen production, hydrogen storage, hydrogenation, hydrogen use and so on. There is a huge space for the development of hydrogen energy industry.
Dongguan Securities pointed out that the current hydrogen is mainly gray hydrogen, accounting for about 95% of the global hydrogen production. Coal to olefin will still be the main way of hydrogen production in China during the 14th Five Year Plan period. At present, the cost of hydrogen production from electrolyzed water is high, and the future development space of proton exchange membrane electrolyzed water (PEM) is broad. At present, the hydrogen storage technology is mainly high-pressure gaseous hydrogen storage. The localization of hydrogen storage bottles will be accelerated, and the type IV bottles will be further widely used in the future. Hydrogen fuel cell is the most widely used fifth generation fuel cell at present. As its core component, membrane electrode will greatly open the growth space of the industry with the growth of the demand for hydrogen fuel cell.
The agency said that the national 14th five year plan mentioned the need to accelerate the development of hydrogen energy industry. With the continuous promotion of policies, the hydrogen energy industry chain will be further improved, and the growth space in key areas of the hydrogen energy industry chain will be continuously widened. Recommended Sinoma Science & Technology Co.Ltd(002080) , Guangdong No.2 Hydropower Engineering Company Ltd(002060) , Dongfang Electric Corporation Limited(600875) .
the international oil price broke through $110, and the oil and gas sector broke out again Xinjiang Zhundong Petroleum Technology Co.Ltd(002207) closed 6 limit sectors in a row
On March 3, the oil and gas sector of A-share continued to strengthen. As of press time, Xinjiang Zhundong Petroleum Technology Co.Ltd(002207) rose by the limit, and the stock has closed six limit sectors in a row. Renzhi shares soared, with Xinjiang Beiken Energy Engineering Co.Ltd(002828) , Tong Petrotech Corp(300164) , Guanghui Energy Co.Ltd(600256) and other stocks leading the rise. On the news side, the conflict between Russia and Ukraine is still continuing. Affected by geopolitical tensions, the rise of international oil prices is unabated and stands at the $110 mark.
According to the combing of China Singapore longitude and latitude, China’s refined oil prices have experienced three rounds of adjustment in 2022, showing a pattern of “three rises, zero falls and zero stranding”. Coupled with the increase on December 31, 2021, the oil price shows a trend of “four consecutive rises”. After this round of price adjustment is implemented, China’s refined oil price will hit another “five consecutive rises”.
For the future, Zhao Wei, chief economist of Sinolink Securities Co.Ltd(600109) said in a recent article that the oil price is still easy to rise but difficult to fall in 2022. Since entering the shale oil era, the sharp expansion of crude oil production in the United States has reduced the ceiling of crude oil price to $120 / barrel. Looking forward to the future, OPEC’s pricing power is strengthened and the credibility of increasing production continues to be verified. The subsequent increase of shale oil production in the United States is weak, which may not worry about the disturbance brought by the supply side. If the incremental impact of crude oil brought by Iran is falsified and the superposition of global crude oil demand is still in the improvement channel, for oil prices, 100 US dollars / barrel may only mean the first half, and the possibility of reaching 120 US dollars / barrel cannot be ruled out.
CITIC futures research report believes that the space above the oil price depends on the escalation of the conflict between Russia and Ukraine. If the military conflict continues to escalate, resulting in continuous supply interruption, it may push up oil prices further. If the oil price returns to the diplomatic channel quickly, it will help to calm the pressure of the peaceful settlement of the oil price.
Guotai Junan Securities Co.Ltd(601211) said that the future impact of geopolitical conflict on Russia’s crude oil exports remains to be seen. It is suggested to wait for the reverse opportunity and lay out more definite recovery trend opportunities in the next two years. It is expected to accelerate the recovery of crude oil warehouse clearance and environmental protection policy in the next two years, but it is expected to speed up the recovery of crude oil transportation capacity in the future.
coal stocks soared again. Is there a historic allocation opportunity? Focus on three main lines
In early trading on Thursday, coal stocks continued to be strong. As of press time, Yunnan Coal & Energy Co.Ltd(600792) , Beijing Haohua Energy Resource Co.Ltd(601101) and others rose by the limit, and Jinneng Holding Shanxi Coal Industry Co.Ltd(601001) , Shanxi Coal International Energy Group Co.Ltd(600546) , Jinneng Science&Technology Co.Ltd(603113) , Shanxi Lu’An Environmental Energydev.Co.Ltd(601699) and others followed suit. According to the news, on March 2, the general office of the national development and Reform Commission issued a notice to make deployment arrangements for further signing medium and long-term coal contracts and strengthening the supervision of contract performance. The notice emphasizes that all medium and long-term coal contracts in 2022 will be entered and confirmed through the online platform of the national coal trading center, and the integrity performance commitment will be signed online, which will be included in the integrity performance guarantee platform of the “credit China” website for supervision. All contracts signed and entered shall be negotiated and determined as soon as possible in accordance with the reasonable range specified in the notice of the national development and Reform Commission on further improving the coal market price formation mechanism.
Shanxi Securities Co.Ltd(002500) also pointed out that the previous landing of the price range of the long-term association had a certain impact on the market sentiment, but under the continuous conflict between Russia and Ukraine, the international coal price remained high, and China’s coal price was still supported. With the end of the Winter Olympic Games, the resumption of work and production in the downstream led to the strengthening of the coal demand side, and it is expected that enterprises with high-quality resources are expected to repair the valuation.
Cinda Securities said that the problem of industry capacity cycle mismatch has not changed. When the demand side continues to increase and the elasticity of the supply side is very small, coal prices are easy to rise and difficult to fall. It is a general trend to go up after maintaining a high level and shaking, and the industry business cycle will continue to improve.
In terms of allocation, the research report said that it is right to allocate the coal sector at this stage, and it is recommended to continue to pay attention to the historic allocation opportunities of coal. Focus on three main lines: first, under the tight supply and demand of coal in China, low inventory, high price and policy encouragement to increase production and ensure supply, favorable listed companies of thermal coal: Yanzhou Coal Mining Company Limited(600188) , Shaanxi Coal Industry Company Limited(601225) , China Shenhua Energy Company Limited(601088) , China Coal Energy Company Limited(601898) ; Second, it is suggested to pay attention to the southwest coking coal leader Guizhou Panjiang Refined Coal Co.Ltd(600395) , which has a large space for endogenous extension, and the pioneer of state-owned enterprise reform Pingdingshan Tianan Coal Mining Co.Ltd(601666) ; Third, it is suggested to pay attention to Shanxi Coking Coal Energy Group Co.Ltd(000983) , Jinneng Holding Shanxi Coal Industry Co.Ltd(601001) , which have great potential for extensive expansion brought by the increase of asset securitization rate of state-owned coal groups.
active trend of assisted reproduction concept Guangdong Hybribio Biotech Co.Ltd(300639) and other big rises Everjoy Health Group Co.Ltd(002162) two connected boards
The concept of assisted reproduction rose strongly in intraday trading on the 3rd, Everjoy Health Group Co.Ltd(002162) limit, Dajia Weikang, Guangdong Hybribio Biotech Co.Ltd(300639) and other outstanding performances, Xilong Scientific Co.Ltd(002584) , Hubei Goto Biopharm Co.Ltd(300966) , Changjiangrunfa Health Industry Co.Ltd(002435) , Hunan Jingfeng Pharmaceutical Co.Ltd(000908) . It is worth noting that Everjoy Health Group Co.Ltd(002162) has performed strongly recently. Since February 16, the stock has risen by about 57%, of which the limit has been raised continuously in recent two trading days.
The company recently pointed out in the announcement that in the field of specialized medical services for obstetrics, gynecology and reproduction, in August 2016, the company acquired 60% equity of unity fertility center, LLC (“Rixing artificial reproduction center”) in Los Angeles with its own funds of US $1.5 million, which can provide legal IVF medical services in the United States. In December 2017, Shanghai Everjoy Health Group Co.Ltd(002162) Medical Investment Management Co., Ltd., a wholly-owned subsidiary of the company, signed a cooperation and co construction agreement with Yichun maternal and child health hospital. In May 2018, the assisted reproduction center of Yichun maternal and child health hospital obtained the operation qualification of assisted reproduction IVF. Yuexin medical is responsible for the instruments and equipment required to be purchased during the preparatory period of the reproductive center, contacting experts related to assisted reproduction at home and abroad, promoting technical exchange and cooperation, assisting in external customer service and development, and assisting the reproductive center in introducing and retaining talents. Both parties shall reasonably calculate the cost sharing and service fee according to the proportion of resource investment of both parties. Yuexin medical’s income comes from the depreciation, amortization and recovery of invested resources and the service fee calculated according to the operating benefits of the services provided.
The company also pointed out that the current revenue of elderly care service business income and maternity and reproduction business income is small, and the subsequent company will carry out business in combination with market conditions. It is expected that the above two businesses will not have a significant impact on the company’s performance in 2022.
In terms of industry news, recently, the Beijing Medical Insurance Bureau, the health commission and the human resources and Social Security Bureau issued the notice on standardizing and adjusting the price of some medical services, uniformly priced 53 assisted reproductive technology projects such as in vitro fertilization and embryo culture, and included 16 of them in class a medical insurance (outpatient only), which will be implemented from March 26, 2022.
Kaiyuan Securities said that the inclusion of 16 assisted reproductive projects into class a medical insurance this time is conducive to the improvement of IVF service penetration, and the fertility policy will be more active under the national policy environment of encouraging three births. However, considering the high proportion of first-line patients from other places and the pilot promotion of direct settlement of outpatient expenses in different places in China, It is expected that IVF service penetration will not increase rapidly in a short time, but will gradually rise; Secondly, in terms of supply, the industry threshold is still very high, high-quality IVF licenses are scarce, medical insurance qualification puts forward higher requirements for IVF institutions, and the competitive advantage of leading institutions will be more prominent; Finally, in terms of profitability, the overall difference between this pricing and the previous pricing is small, and has little impact on VIP and other high-end special needs services. Therefore, the profitability of IVF institutions is expected to be maintained.
the Ministry of industry and information technology emphasizes to solidly promote the construction of application related industrial chains such as data centers or attract attention (attached shares)
On March 1, Zhang Yunming, Vice Minister of the Ministry of industry and information technology, attended the 2022 China Internet Development Symposium and delivered a speech.
Zhang Yunming stressed that we will solidly promote the construction and application of 5g, gigabit optical network, data center, industrial Internet and Internet of vehicles. Be the leader of digital technology innovation and breakthrough. We will intensify efforts to tackle key technical problems in mobile communications, integrated circuits, key software, big data, artificial intelligence and other fields.
The Ministry of industry and information technology once again emphasizes the construction and application of data center. Earlier, on February 17, the national development and Reform Commission, the central network information office, the Ministry of industry and information technology and the National Energy Administration jointly issued a notice agreeing to start the construction of National Computing hub nodes in 8 places, including Beijing, Tianjin and Hebei, the Yangtze River Delta, Guangdong, Hong Kong and Macao Dawan District, Chengdu and Chongqing, Inner Mongolia, Guizhou, Gansu and Ningxia, and planned 10 national data center clusters.
In terms of A-share investment, Citic Securities Company Limited(600030) believes that from the long-term promotion of the policy, the calculation from the east to the West will be a national long-term project plan, and the impact on the industry will be long-term sustainable. In view of the two questions of the market, the changes brought by the East digital West computing in the industry mainly include: on the transmission side, the construction of long-distance optical network first; On the computing side, servers and other basic computing facilities will maintain the steady growth attribute. At the same time, the procurement led by state-owned assets will be more inclined to domestic independent and controllable domestic CPU and other core components.
The agency pointed out that the state led construction of computing power will bring long-term growth support to ICT equipment. On the computing side, the core recommends Inspur Electronic Information Industry Co.Ltd(000977) , and suggests paying attention to Unisplendour Corporation Limited(000938) , Shenzhen Envicool Technology Co.Ltd(002837) , Nanjing Canatal Data-Centre Environmental Tech Co.Ltd(603912) ; On the transmission side, with the computing power inclining to the west, the construction of long-distance optical network connection is emphasized in the context of digital network coordination. The core recommends the optical module manufacturer Zhongji Innolight Co.Ltd(300308) . It is recommended to pay attention to Suzhou Tfc Optical Communication Co.Ltd(300394) , Zte Corporation(000063) , Eoptolink Technology Inc.Ltd(300502) , Jiangsu Zhongtian Technology Co.Ltd(600522) , Hengtong Optic-Electric Co.Ltd(600487) , Yangtze Optical Fibre And Cable Joint Stock Limited Company(601869) . Purchasers with state-owned assets such as operators are more inclined to purchase independently controllable products. It is suggested to pay attention to the domestic CPU manufacturer China Greatwall Technology Group Co.Ltd(000066) and so on. In terms of IDC construction, it is suggested to pay attention to China Mobile, China Telecom Corporation Limited(601728) , China United Network Communications Limited(600050) , Shanghai Baosight Software Co.Ltd(600845) , Beijing Sinnet Technology Co.Ltd(300383) , Kehua Data Co.Ltd(002335) , Guangdong Aofei Data Technology Co.Ltd(300738) , etc.
